Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
dc.creator | Jatuworapruk, Kanon | |
dc.creator | Montgomery, Anna | |
dc.creator | Gianfrancesco, Milena | |
dc.creator | Conway, Richard | |
dc.creator | Durcan, Laura | |
dc.creator | Graef, Elizabeth R. | |
dc.creator | Jayatilleke, Arundathi | |
dc.creator | Keen, Helen | |
dc.creator | Kilian, Adam | |
dc.creator | Young, Kristen | |
dc.creator | Carmona, Loreto | |
dc.creator | Cogo, Adriana Karina | |
dc.creator | Duarte-Garcia, Ali | |
dc.creator | Gossec, Laure | |
dc.creator | Hasseli, Rebecca | |
dc.creator | Hyrich, Kimme L. | |
dc.creator | Langlois, Vincent | |
dc.creator | Sigurdardottir, Valgerdur | |
dc.creator | Sparks, Jeffrey A. | |
dc.creator | Strangfeld, Anja | |
dc.creator | Xavier, Ricardo M. | |
dc.creator | Bhana, Suleman | |
dc.creator | Gore-Massy, Monique | |
dc.creator | Hausmann, Jonathan S. | |
dc.creator | Liew, Jean W. | |
dc.creator | Sirotich, Emily | |
dc.creator | Sufka, Paul | |
dc.creator | Wallace, Zach | |
dc.creator | Machado, Pedro M. | |
dc.creator | Yazdany, Jinoos | |
dc.creator | Grainger, Rebecca | |
dc.creator | Robinson, Philip C. | |
dc.date.accessioned | 2022-12-20T19:23:40Z | |
dc.date.available | 2022-12-20T19:23:40Z | |
dc.date.issued | 2022-08-24 | |
dc.identifier.citation | Jatuworapruk, K., Montgomery, A., Gianfrancesco, M., Conway, R., Durcan, L., Graef, E.R., Jayatilleke, A., Keen, H., Kilian, A., Young, K., Carmona, L., Cogo, A.K., Duarte-García, A., Gossec, L., Hasseli, R., Hyrich, K.L., Langlois, V., Lawson-Tovey, S., Malcata, A., Mateus, E.F., Schafer, M., Scirè, C.A., Sigurdardottir, V., Sparks, J.A., Strangfeld, A., Xavier, R.M., Bhana, S., Gore-Massy, M., Hausmann, J., Liew, J.W., Sirotich, E., Sufka, P., Wallace, Z., Machado, P.M., Yazdany, J., Grainger, R. and Robinson, P.C. (2022), Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry. ACR Open Rheumatology, 4: 948-953. https://doi.org/10.1002/acr2.11495 | |
dc.identifier.issn | 2578-5745 | |
dc.identifier.doi | http://dx.doi.org/10.34944/dspace/8186 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12613/8215 | |
dc.description.abstract | Objective: To describe people with gout who were diagnosed with coronavirus disease 2019 (COVID-19) and hospitalized and to characterize their outcomes. Methods: Data on patients with gout hospitalized for COVID-19 between March 12, 2020, and October 25, 2021, were extracted from the COVID-19 Global Rheumatology Alliance registry. Descriptive statistics were used to describe the demographics, comorbidities, medication exposures, and COVID-19 outcomes including oxygenation or ventilation support and death. Results: One hundred sixty-three patients with gout who developed COVID-19 and were hospitalized were included. The mean age was 63 years, and 85% were male. The majority of the group lived in the Western Pacific Region (35%) and North America (18%). Nearly half (46%) had two or more comorbidities, with hypertension (56%), cardiovascular disease (28%), diabetes mellitus (26%), chronic kidney disease (25%), and obesity (23%) being the most common. Glucocorticoids and colchicine were used pre-COVID-19 in 11% and 12% of the cohort, respectively. Over two thirds (68%) of the cohort required supplemental oxygen or ventilatory support during hospitalization. COVID-19-related death was reported in 16% of the overall cohort, with 73% of deaths documented in people with two or more comorbidities. Conclusion: This cohort of people with gout and COVID-19 who were hospitalized had high frequencies of ventilatory support and death. This suggests that patients with gout who were hospitalized for COVID-19 may be at risk of poor outcomes, perhaps related to known risk factors for poor outcomes, such as age and presence of comorbidity. | |
dc.format.extent | 6 pages | |
dc.language | English | |
dc.language.iso | eng | |
dc.relation.ispartof | COVID-19 Research | |
dc.relation.haspart | ACR Open Rheumatology, Vol. 4, No. 11 | |
dc.relation.isreferencedby | Wiley Open Access | |
dc.rights | Attribution-NonCommercial-NoDerivs CC BY-NC-ND | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.title | Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry | |
dc.type | Text | |
dc.type.genre | Journal article | |
dc.description.department | Medicine | |
dc.description.department | Section of Rheumatology | |
dc.relation.doi | https://doi.org/10.1002/acr2.11495 | |
dc.ada.note | For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu | |
dc.description.schoolcollege | Lewis Katz School of Medicine | |
dc.creator.orcid | Jayatilleke|0000-0003-0875-4280 | |
dc.temple.creator | Jayatilleke, Arundathi | |
refterms.dateFOA | 2022-12-20T19:23:40Z |